Some states are giving 1st priority for monoclonal antibodies to unvaccinated patients

The Biden administration last week took a more active role in distributing monoclonal antibodies, a highly effective treatment for people recently infected with COVID-19 and at an elevated risk of otherwise being hospitalized, as demand for the antibody cocktails had ramped up, mostly in Southern states with lower vaccination rates. Federal distribution means those high-usage states will likely have to prioritize who gets the federally funded treatments, and some have decided to treat unvaccinated people first.

Among those states is Tennessee, The Washington Post reports. "Demand is outstripping supply right now," said Karen Bloch, medical director of the antibody infusion clinic at Vanderbilt University Medical Center, and while prioritizing the unvaccinated for her clinic's 80 infusion appointments a day "rub people the wrong way," people who haven't been immunized are much more likely to be hospitalized and die from COVID-19.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.